title: Emergent pediatric anticoagulation reversal using a 4-factor prothrombin complex concentrate.
authors.affiliation: Department of Pharmacy Services, University of California Davis Medical Center, 2315 Stockton Blvd, Sacramento, CA 95817. Electronic address: chradams@ucdavis.edu.
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Adams
authors.affiliation: Department of Pharmacy Services, Owensboro Health Regional Hospital, Owensboro, KY.
authors.forename: Kristan E
authors.initials: KE
authors.lastname: Vollman
authors.affiliation: Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
authors.forename: Evan L
authors.initials: EL
authors.lastname: Leventhal
authors.affiliation: Departments of Emergency Medicine and Pharmacy, University of Rochester Medicine, Rochester, NY.
authors.forename: Nicole M
authors.initials: NM
authors.lastname: Acquisto
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D002648:Child; D017984:Enoxaparin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006261:Headache / Q000209:etiology; D006470:Hemorrhage / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology; D006494:Heparin Antagonists / Q000627:therapeutic use*; D006801:Humans; D011479:Protamines / Q000627:therapeutic use*; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D001779:Blood Coagulation Factors; D017984:Enoxaparin; D006494:Heparin Antagonists; D011479:Protamines; D014812:Vitamin K; C025667:prothrombin complex concentrates; D014859:Warfarin